News
Analysts’ view on the stock has dramatically changed over the past few months. Currently, only 21% of the 29 analysts ...
Here are the five things you need to know today, including U.S. News' hospital rankings, MGB layoff costs, CPA licenses, buffalo wings and C-level gig work ...
El Mundo on MSN53m
Sarepta will resume gene therapy shipments after FDA review of recent patient deathShares of beleaguered drugmaker Sarepta Therapeutics jumped in afterhours trading Monday after the company said it would resume shipping its gene therapy for some patients, following a brief pause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results